drugset / Trial / NCT00691808
Study of LX6171 in Elderly Volunteers With Age Associated Memory Impairment
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to determine the safety, tolerability, and effectiveness of 2 dose levels of LX6171 given over 28 days in patients with Age Associated Memory Impairment (AAMI).
Timeline
- Start
- 2008-02
- Primary completion
- 2008-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LX6171 | Unknown | — | Oral |